About MBX Capital
Formative-stage investor making $1–2.5M first checks targeting ≥5% equity in deep-health systems (biology, chemistry, AI/ML, robotics, clinical medicine), leveraging a private expert network that sources and vets deals. The firm continues to build its presence across the venture capital landscape.

